COVID / CORONAVIRUS + LATENT VIRUSES + BIOFILM
I. CORONAVIRUS - CORE
1. N.E.M.O. Coronavirus (COVID-related)
2. N.E.M.O. Human Coronaviruses (COVID-related)
3. N.E.M.O. Respiratory Coronaviruses (COVID-related)
4. N.E.M.O. Neurotropic Coronaviruses (COVID-related)
5. N.E.M.O. Enteric Coronaviruses (COVID-related)
II. MAJOR TYPES
6. N.E.M.O. SARS-CoV (COVID-related)
7. N.E.M.O. SARS-CoV-2 (COVID-19
8. N.E.M.O. MERS-CoV (COVID-related)
III. COMMON HUMAN CORONAVIRUSES
9. N.E.M.O. HCoV-229E (COVID-related)
10. N.E.M.O. HCoV-NL63 (COVID-related)
11. N.E.M.O. HCoV-OC43 (COVID-related)
12. N.E.M.O. HCoV-HKU1 (COVID-related)
IV. COVID SYSTEM
13. N.E.M.O. COVID-19 (general)
14. N.E.M.O. COVID-19 acute phase
15. N.E.M.O. COVID-19 chronic phase
16. N.E.M.O. Long COVID syndrome
17. N.E.M.O. Post-COVID condition
V. LATENT / HIDDEN FORMS (COVID SYSTEM)
18. N.E.M.O. COVID latent viral state
19. N.E.M.O. COVID dormant virus
20. N.E.M.O. COVID hidden viral reservoirs
21. N.E.M.O. COVID intracellular persistence
22. N.E.M.O. COVID immune evasion
23. N.E.M.O. COVID viral reactivation
24. N.E.M.O. COVID chronic persistence
VI. LOCALIZATION (COVID SYSTEM)
25. N.E.M.O. COVID - CNS reservoirs
26. N.E.M.O. COVID - vagus nerve
27. N.E.M.O. COVID - gut-associated lymph tissue
28. N.E.M.O. COVID - lymph nodes
29. N.E.M.O. COVID - bone marrow
30. N.E.M.O. COVID - intracellular compartments
VII. BIOFILM SYSTEM (COVID)
Core:
31. N.E.M.O. COVID biofilm
32. N.E.M.O. COVID viral biofilm
33. N.E.M.O. COVID mixed biofilm
Structure:
34. N.E.M.O. COVID biofilm EPS matrix
35. N.E.M.O. COVID biofilm polysaccharide matrix
36. N.E.M.O. COVID biofilm protein matrix
37. N.E.M.O. COVID biofilm DNA matrix
Forms:
38. N.E.M.O. COVID mature biofilm
39. N.E.M.O. COVID immature biofilm
40. N.E.M.O. COVID resistant biofilm
41. N.E.M.O. COVID hidden biofilm
Interactions:
42. N.E.M.O. COVID + Candida biofilm
43. N.E.M.O. COVID + bacterial biofilm
44. N.E.M.O. COVID + fungal biofilm
Behavior:
45. N.E.M.O. COVID biofilm protection
46. N.E.M.O. COVID biofilm immune evasion
47. N.E.M.O. COVID biofilm persistence
VIII. VIRAL MECHANISMS (COVID)
48. N.E.M.O. COVID replication cycle
49. N.E.M.O. COVID intracellular survival
50. N.E.M.O. COVID adaptation
51. N.E.M.O. COVID persistence mechanism
52. N.E.M.O. COVID stealth mechanisms
IX. IMMUNE DYSREGULATION (COVID)
53. N.E.M.O. COVID immune suppression
54. N.E.M.O. COVID immune overactivation
55. N.E.M.O. COVID cytokine imbalance
56. N.E.M.O. COVID chronic inflammation
57. N.E.M.O. COVID immune exhaustion
X. TOXIC / POST-VIRAL EFFECTS (COVID)
58. N.E.M.O. COVID viral toxins
59. N.E.M.O. COVID post-viral toxicity
60. N.E.M.O. COVID neurotoxicity
61. N.E.M.O. COVID oxidative stress
62. N.E.M.O. COVID mitochondrial dysfunction
XI. CO-INFECTIONS (COVID)
63. N.E.M.O. COVID + Candida
64. N.E.M.O. COVID + Aspergillus
65. N.E.M.O. COVID + bacterial biofilm
66. N.E.M.O. COVID + Borrelia
67. N.E.M.O. COVID + Epstein-Barr virus
XII. DETOX & REGULATION (COVID)
68. N.E.M.O. COVID detox pathways
69. N.E.M.O. COVID liver detox support
70. N.E.M.O. COVID lymphatic drainage
71. N.E.M.O. COVID neuroinflammation reduction
72. N.E.M.O. COVID immune regulation